Abstract
BackgroundLarge bone defects in canines usually require assistance to achieve healing. Implantation of osteoinductive factors can promote bone healing, while transplantation of osteoprogenitor cells can enhance bone regeneration. We hypothesized that implantation of an osteoinductive factor, recombinant human bone morphogenetic protein-2 (rhBMP-2), combined with osteoprogenitor cells, bone marrow-derived mesenchymal stromal cells (BMSCs), would synergistically promote bone healing. In this study, we examined the combined effects of Escherichia coli-derived rhBMP-2 and BMSCs on bone healing after implantation into canine ulnar defects.ResultsCritical-sized osteoperiosteal segmental defects (2.5 cm) were created in the ulnae of healthy female beagle dogs, and implanted with combinations of E. coli-derived rhBMP-2 (560 or 140 μg) and autologous BMSCs (107, 105, or 0 cells). In the present study,18 forelimbs of nine healthy purpose-bred female beagles were used. All six treatment groups contained three forelimbs, and the animals were euthanized after 12 weeks. The control groups (560 and 140 μg/0 cells) were cited from our previous study to reduce the number of experimental animals. Radiographically, the regenerated bone width was significantly increased in the 560 or 140 μg with 107 and 105 cells groups compared with the 0 cells groups. By quantitative CT, the bone mineral density was higher in the 560 μg with 107 and 105 cells groups, while non-uniformity of the bone mineral density was improved in the 560 μg with 107 and 105 cells groups and 140 μg/107 cells group. Mechanically, the maximum loads at failure were significantly higher in the 560 μg with 107 and 105 cells groups. Histologically, the regenerated bone was well-developed and contained osteocyte-like cells marrow cavities, and vessels. However, the osteoclasts and osteoblasts were hardly observed. The osteocyte-like cell numbers were significantly higher in the 560 μg with 107 and 105 cells and 140 μg with 107 and 105 cells groups.ConclusionsImplantation of E. coli-derived rhBMP-2 and BMSCs led to significantly enhanced bone formation, with improved bone mineral density and reduced non-uniformity of the regenerated bone. Combined implantation of rhBMP-2 and BMSCs may be useful for promotion of bone healing in critical-sized defects in canines.
Highlights
Large bone defects in canines usually require assistance to achieve healing
In the present study, implantation of E. coli-derived recombinant human bone morphogenetic protein-2 (rhBMP-2) combined with bone marrow-derived mesenchymal stromal cells (BMSCs) increased the amount of bone formation, and stabilized the bone mineral density and reduced the non-uniformity
The results of the present study suggest that transplantation of osteoprogenitor cells together with rhBMP-2 is important for reconstruction of large bone defects to achieve stable therapeutic outcomes
Summary
Implantation of osteoinductive factors can promote bone healing, while transplantation of osteoprogenitor cells can enhance bone regeneration. We hypothesized that implantation of an osteoinductive factor, recombinant human bone morphogenetic protein-2 (rhBMP-2), combined with osteoprogenitor cells, bone marrow-derived mesenchymal stromal cells (BMSCs), would synergistically promote bone healing. We examined the combined effects of Escherichia coli-derived rhBMP-2 and BMSCs on bone healing after implantation into canine ulnar defects. Recombinant human bone morphogenetic protein-2 (rhBMP-2) is used in veterinary medicine for treatment of canines with non-unions [8, 9], arthrodesis [10, 11], and mandibular defects [12, 13]. Because rhBMP-2 promotes bone regeneration by activating progenitor cell recruitment, proliferation, and differentiation [15,16,17,18,19], we hypothesized that implantation of rhBMP-2 combined with osteoprogenitor cells would improve bone regeneration
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.